Peng Hu

Dr. Peng Hu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2024 in International Journal of Surgery
Verified
Journal Article
Open access
FWFei Wang
Fei Wang
CLChuanxi Lai
Chuanxi Lai
YLYiming Lv
Yiming Lv
FZFeixiang Zhang
Feixiang Zhang
LSLiming Shi
Liming Shi
SDSheng Dai
Sheng Dai
Background: Conventional neoadjuvant chemoradiotherapy (nCRT) yields a pathologic complete response (pCR) rate of 15–30% for locally advanced rectal cancer (LARC). This study ventures to shift this paradigm by incorporating short-course nCRT with immunotherapy, specifically Envafolimab, to achieve improved treatment efficacy and possibly redefine the standard of care for LARC. Materials and methods: The PRECAM study is a prospective, single-arm, phase 2 clinical trial for LARC in patients with microsatellite stable (MSS) tumors. Participants received short-course radiotherapy (25Gy/5f), followed by two cycles of CAPEOX chemotherapy and six weekly doses of Envafolimab, a PD-L1 antibody, before total mesorectal excision surgery. The primary endpoint was the pCR rate. Results: From April to December 2022, 34 patients were enrolled, of whom 32 completed the study, each diagnosed with an MSS rectal adenocarcinoma. All patients underwent preoperative CRT combined with Envafolimab. Remarkably, a pCR rate of 62.5% (20/32) was attained, and a significant pathologic response rate of 75% (24/32) was achieved. Additionally, 21 of 32 participants achieved a neoadjuvant rectal (NAR) score below 8, suggesting an effective treatment response. Common adverse events included tenesmus (78.1%), diarrhea (62.5%), and leukocyte decrease (40.6%). Two Grade 3 adverse events were noted, one related to liver function abnormality and the other to a decrease in platelet count. Surgical procedures were performed in all cases, with minor complications, including ileus, infections, and anastomotic leakage. As of this report, there have been no reported cases of recurrence or death during the follow-up period, ranging from 12 to 20 months. Conclusion: In LARC patients exhibiting MSS tumors, combining short-course nCRT with Envafolimab demonstrated favorable efficacy, leading to a significant pCR rate. Minor adverse effects and surgical complications were observed. These preliminary but promising results underscore the potential of this approach and call for further exploration and validation through a randomized controlled trial.

18 January 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
HLHai Liu
Hai Liu
RHRunying Huang
Runying Huang
JSJingjing Shan
Jingjing Shan
XXXuyun Xie
Xuyun Xie
WCWANG CHONGWEI
WANG CHONGWEI
XSXiaonan Sun
Xiaonan Sun
The aim of this study was to identify Artemis as a predictive biomarker for guiding preoperative chemoradiotherapy in locally advanced rectal cancer. The resection specimens were collected from 50 patients with rectal cancer who underwent preoperative chemoradiotherapy. Artemis expression in biopsy tissues was evaluated using immunohistochemical staining according to the percentage of positively stained cells combined with staining intensity. Among the 50 patients, 36 (72%) had a weakly positive Artemis protein expression, 10 (20%) had a moderately positive expression, and 4 (8%) showed a strongly positive expression. The criteria of magnetic resonance imaging tumor regression grade (mrTRG) and pathological rectal cancer regression grade (RCRG) were used to assess the tumor response to chemoradiotherapy. Correlation analysis shows that there is a significant negative correlation between high Artemis immunoscore and treatment response (r = −0.532, p < 0.001). The results imply that high Artemis expression was associated with poor treatment response. Our study suggested a potential role of Artemis as a predictive biomarker of the tumor response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.

31 January 2025 in Pattern Analysis and Applications
Verified
Journal Article
Closed access
PDF file
TZTianning Zhao
Tianning Zhao
GDGuoping Ding
Guoping Ding
ZLZhenyang Liu
Zhenyang Liu
PHPeng Hu
Peng Hu
HWHangping Wei
Hangping Wei
JDJiajun Ding
Jiajun Ding

23 October 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
QHQiuhan Huang
Qiuhan Huang
MYMiaojia Yan
Miaojia Yan
YWYan Wu
Yan Wu
JCJieyi Cao
Jieyi Cao
YQYonggang Qiu
Yonggang Qiu
Jihong SunJihong Sun
Jihong Sun
Background/Objectives: Preoperative identification of malignant transformation in rectal adenomas (RAs) is challenging because endoscopic biopsy may not sample focal malignant components. This study aimed to develop and externally validate an interpretable multimodal model for preoperative risk stratification of malignant transformation in RAs. Methods: In this retrospective two-center study, 359 surgically treated patients were allocated to training (n = 143), internal validation (n = 61), and external validation (n = 155) cohorts. Radiomic features derived from high-resolution T2-weighted imaging (HRT2WI) and diffusion-weighted imaging (DWI), clinical biomarkers, and CT-derived body composition metrics were evaluated. Five machine learning algorithms were compared for each radiomics signature. The final combined logistic regression model integrated the selected HRT2WI and DWI radiomics model-predicted probabilities with clinical and body composition predictors. Discrimination, calibration, and decision curve analyses were performed. Results: The malignant transformation was present in 65/143 patients (45.5%) in the training cohort and 91/155 (58.7%) in the external cohort, a difference of 13.3 percentage points. The combined model achieved area under the receiver operating characteristic curve (AUC) values of 0.956 (95% CI, 0.922–0.981), 0.908 (95% CI, 0.830–0.970), and 0.867 (95% CI, 0.803–0.919) in the training, internal validation, and external validation cohorts, respectively. In external validation, the combined model outperformed the four component models and the junior radiologist (all p < 0.05); its performance did not differ significantly from that of the senior radiologist (p = 0.093). Note that this reader comparison included only one junior and one senior radiologist and is exploratory and cannot support general conclusions regarding model performance versus radiologists in broader clinical practice. SHapley Additive exPlanations (SHAP) analysis identified the visceral-to-subcutaneous fat ratio (VSR), DWI radiomics model-predicted probability, and the neutrophil-to-lymphocyte ratio (NLR) as the leading contributors to the combined model. Conclusions: This interpretable two-center model showed promising discrimination for preoperative risk stratification of malignant transformation in surgically treated RAs. It may help identify patients who warrant further preoperative assessment or multidisciplinary discussion. Prospective multicenter evaluation is required before clinical implementation.

29 December 2022 in Ultrasound Quarterly
Verified
Journal Article
Closed access
LXLi-Long Xu
Li-Long Xu
LZLing Zhou
Ling Zhou
XLXiao Liang
Xiao Liang
LZLin-Lin Zheng
Lin-Lin Zheng
HXHai-Shan Xu
Hai-Shan Xu
SLShiyan Li
Shiyan Li
The clinical data of 15 cases that planned to receive totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy were retrospectively collected. Before the stage 1 operation, the size and number of the tumors in future liver remnant (FLR) and the presence of cancer embolus in the portal vein were assessed using contrast-enhanced ultrasound (CEUS) and contrast-enhanced computed tomography (CECT). Before the stage 2 operation, CEUS was performed to assess the presence of traffic blood flow between the diseased liver and FLR after round-the-liver ligation. Before the stage 1 operation, 5 cases with tumors in FLR were found by CEUS and 6 cases were found by CECT (P > 0.05). Similarly, CEUS found 5 cases with cancer thrombus in portal vein, and CECT found 7 cases (P = 0.500). The consistency between the 2 modalities was good (κ = 0.857, P < 0.05, κ = 0.727, P < 0.05, respectively). Before the stage 2 operation, CEUS confirmed that there were 7 cases without traffic blood flow between the diseased liver and FLR, and 3 cases with residual traffic blood flow. The daily growth rate of FLR in the group without traffic blood flow (mean rank = 7.00) was higher than that in the group with traffic blood flow (2.00) significantly (P < 0.05). Contrast-enhanced ultrasound is a promising application in the preoperative evaluation of totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy.